On June 26, 2024, Reuters wrote a piece announcing the looming threat of plans to offer preemptive bird flu injection to the people of Finland who work with animals.
It’s important that the people of the world understand something about the so-called AUDENZ™ (Influenza A (H5N1) Monovalent Vaccine, Adjuvanted), another product in clinical trials that will soon be offered to the public to fight ‘bird flu’.
Some details: It’s a 2-doser – 21 days apart. Anaphylaxis is counter-indicated and a precautionary warning pertaining to Guillain-Barré syndrome is listed in the prescribing information sheet.